.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Dow
Argus Health
Moodys
Chubb
Chinese Patent Office
Mallinckrodt
Teva
UBS
Medtronic

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087859

« Back to Dashboard
NDA 087859 describes SPS, which is a drug marketed by Cmp Pharma Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the SPS profile page.

The generic ingredient in SPS is sodium polystyrene sulfonate. There are one thousand three hundred and ninety-two drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.

Summary for NDA: 087859

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antidotes, Deterrents, and Toxicologic Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 087859

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SPS
sodium polystyrene sulfonate
SUSPENSION;ORAL, RECTAL 087859 ANDA CMP Pharma, Inc. 46287-006 46287-006-01 473 mL in 1 BOTTLE (46287-006-01)
SPS
sodium polystyrene sulfonate
SUSPENSION;ORAL, RECTAL 087859 ANDA CMP Pharma, Inc. 46287-006 46287-006-04 120 mL in 1 BOTTLE (46287-006-04)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORAL, RECTALStrength15GM/60ML
Approval Date:Dec 8, 1982TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
US Army
McKinsey
Citi
Medtronic
Deloitte
QuintilesIMS
AstraZeneca
Fuji
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot